tiprankstipranks
Rocket Pharma (RCKT)
NASDAQ:RCKT
US Market
RCKT
Rocket Pharmaceuticals
RESEARCH TOOLSreports
Want to see RCKT full AI Analyst Report?

Rocket Pharmaceuticals (RCKT) Stock News & Sentiment

1,716 Followers
Rocket Pharmaceuticals Monetizes Voucher to Extend Cash Runway
Premium
Company Announcements
Rocket Pharmaceuticals Monetizes Voucher to Extend Cash Runway
7d ago
8K
RCKT
Rocket Pharma Advances Cardiac Gene Therapy Trial, Keeping RCKT on Investors’ Radar
Premium
Company Announcements
Rocket Pharma Advances Cardiac Gene Therapy Trial, Keeping RCKT on Investors’ Radar
19d ago
RCKT
Balancing Early Gene Therapy Validation Against Limited Near-Term Revenue and Pipeline Risk: Rationale for Maintaining a Hold on Rocket
Premium
Ratings
Balancing Early Gene Therapy Validation Against Limited Near-Term Revenue and Pipeline Risk: Rationale for Maintaining a Hold on Rocket
1M ago
RCKT
Rocket Pharmaceuticals: FDA Validation, Non-Dilutive Funding Catalyst, and Pipeline De-Risking Support Buy Rating
Premium
Ratings
Rocket Pharmaceuticals: FDA Validation, Non-Dilutive Funding Catalyst, and Pipeline De-Risking Support Buy Rating
1M ago
RCKT
Rocket Pharmaceuticals: Kresladi Approval, Non‑Dilutive Capital, and Danon Pipeline Progress Underscore Buy Rating Despite Share Weakness
Premium
Ratings
Rocket Pharmaceuticals: Kresladi Approval, Non‑Dilutive Capital, and Danon Pipeline Progress Underscore Buy Rating Despite Share Weakness
1M ago
RCKT
Rocket Pharmaceuticals: First Approval and Extended Cash Runway Offset by Long Path to Meaningful Kresladi Revenues, Warranting a Hold Rating
Premium
Ratings
Rocket Pharmaceuticals: First Approval and Extended Cash Runway Offset by Long Path to Meaningful Kresladi Revenues, Warranting a Hold Rating
1M ago
RCKT
Rocket Pharmaceuticals wins FDA nod for KRESLADI gene therapy
Premium
Company Announcements
Rocket Pharmaceuticals wins FDA nod for KRESLADI gene therapy
1M ago
8K
RCKT
More RCKT News >

RCKT News on the Web

LifeSci Capital Sticks to Their Buy Rating for Rocket Pharmaceuticals (RCKT)
TipRanks News
Bullish
Rocket Pharma Advances Cardiac Gene Therapy Trial, Keeping RCKT on Investors’ Radar
TipRanks News
Neutral
Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Merit Medical Systems (MMSI) and Vaxcyte (PCVX)
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT) and Moderna (MRNA)
TipRanks News
Neutral
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
Zacks
Bearish
Rocket Pharmaceuticals price target raised to $9 from $8 at BofA
TipRanks News
Bullish
Balancing Early Gene Therapy Validation Against Limited Near-Term Revenue and Pipeline Risk: Rationale for Maintaining a Hold on Rocket
TipRanks News
Neutral
Rocket Pharmaceuticals price target raised to $11 from $9 at Leerink
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
RCKT
Sector Average
Media Buzz
This Week3 articles
Weekly Average5.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RCKT’s Media Buzz Sentiment?
3 articles about RCKT were published this week. In an average week, 5.25 articles are published.
    What is RCKT’s weekly average amount of articles?
    In an average week, 5.25 articles about RCKT are published.
      What is RCKT’s News Sentiment?
      100% of articles about RCKT were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week